Metacel accused Rubicon of inducing infringement of its patent (U.S. Patent 10,610,502) for an oral baclofen solution stored at refrigerated temperatures. The core issue was whether Rubicon's proposed label for its generic version, which primarily instructed room temperature storage but permitted refrigeration, would lead users to infringe Metacel's patent. The court affirmed the district court's summary judgment of no infringement, reasoning that Rubicon's label did not encourage the patented storage method. Full case summary